ScholarIQanswers from OpenAlex

Sodium–glucose co‐transporter‐2 inhibitors: an emerging new class of oral antidiabetic drug

PaperCitations, authors & open-access status

Sodium–glucose co‐transporter‐2 inhibitors: an emerging new class of oral antidiabetic drug is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Sodium–glucose co‐transporter‐2 inhibitors: an emerging new class of oral antidiabetic drug have?

ScholarIQcitation count

Sodium–glucose co‐transporter‐2 inhibitors: an emerging new class of oral antidiabetic drug has 179 citations in the OpenAlex counts ScholarIQ stores.

When was Sodium–glucose co‐transporter‐2 inhibitors: an emerging new class of oral antidiabetic drug published?

ScholarIQyear

Sodium–glucose co‐transporter‐2 inhibitors: an emerging new class of oral antidiabetic drug has 2008 year in the ScholarIQ index.

What is the open-access status of Sodium–glucose co‐transporter‐2 inhibitors: an emerging new class of oral antidiabetic drug?

ScholarIQoa status

Sodium–glucose co‐transporter‐2 inhibitors: an emerging new class of oral antidiabetic drug has closed oa status in the ScholarIQ index.

What is the DOI of Sodium–glucose co‐transporter‐2 inhibitors: an emerging new class of oral antidiabetic drug?

ScholarIQdoi

The DOI for Sodium–glucose co‐transporter‐2 inhibitors: an emerging new class of oral antidiabetic drug is on the source record.

What is the PMID of Sodium–glucose co‐transporter‐2 inhibitors: an emerging new class of oral antidiabetic drug?

ScholarIQpmid

The PMID for Sodium–glucose co‐transporter‐2 inhibitors: an emerging new class of oral antidiabetic drug is on the source record.

What is the OpenAlex record for Sodium–glucose co‐transporter‐2 inhibitors: an emerging new class of oral antidiabetic drug?

ScholarIQopenalex

The OpenAlex for Sodium–glucose co‐transporter‐2 inhibitors: an emerging new class of oral antidiabetic drug is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial